Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,624 across all filing types
Latest filing 2023-06-27 Report Publication Anno…
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
Notification Letter and Request Form to Non-registered holders - Notice of Publication of Extraordinary General Meeting Circular ("Current Corporate Communications")
Report Publication Announcement Classification · 100% confidence The document is a notification letter from RemeGen Co., Ltd. addressed to non-registered shareholders regarding the publication of an Extraordinary General Meeting (EGM) circular. It provides information on how shareholders can access the circular electronically or request a printed version. The document includes a request form for shareholders to indicate their preference for receiving corporate communications. There is no substantive financial data, analysis, or detailed report content present. The document is essentially an announcement about the availability of a corporate communication (the EGM circular) rather than the circular itself. According to the "Menu vs Meal" rule, such a notification letter is classified as a Report Publication Announcement (RPA).
2023-06-27 English
(1) PROPOSED ADOPTION OF THE SECOND H SHARE AWARD AND TRUST SCHEME&#x3b; (2) PROPOSED AUTHORIZATION TO THE BOARD AND/OR THE DELEGATEE TO HANDLE MATTERS PERTAINING TO THE SECOND H SHARE AWARD AND
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from the Board of RemeGen Co., Ltd. regarding the proposed adoption of the Second H Share Award and Trust Scheme, authorization to the Board to handle matters related to the scheme, and notice of the 2023 first extraordinary general meeting (EGM). It includes detailed information about the scheme, definitions, and a notice of the EGM where shareholders will vote on the proposal. The document is lengthy (15,000 characters) and contains substantive content related to governance and shareholder voting matters. It is not a financial report, earnings release, or audit report. It is not a proxy solicitation or voting results announcement but rather a circular providing information and notice for an upcoming shareholder meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings such as EGMs.
2023-06-27 English
CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES
Board/Management Information Classification · 95% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding changes in the company secretary and authorised representative positions, including a waiver from strict compliance with certain listing rules. It details personnel changes in senior management roles related to company secretarial functions and compliance with stock exchange rules. There is no financial data, earnings information, or report publication mentioned. The content focuses on management changes and regulatory compliance related to company officers. Therefore, this fits the category of Board/Management Information (MANG). The document length is 4497 characters, which is consistent with an announcement rather than a full report.
2023-06-26 English
SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information Classification · 100% confidence The document is titled 'SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF OVERSEAS CHINESE TOWN (ASIA) HOLDINGS LIMITED' and contains detailed sections on the company's memorandum and articles of association, including company objects, share capital, board of directors, meetings, and other governance-related provisions. There is no indication of financial data, audit information, earnings, or other financial reporting. The content is focused on the company's internal rules, governance structure, and corporate regulations. Therefore, this document fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not just an announcement or summary.
2023-06-20 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 20 JUNE 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled 'POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 20 JUNE 2023' and details the voting outcomes on various resolutions at the AGM, including re-appointments, re-elections, and amendments to the memorandum and articles of association. It references the AGM Notice and Circular but does not contain the full AGM materials or presentations. The document is approximately 6,181 characters, which is relatively short and focused solely on announcing the voting results. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)', which covers official results from shareholder votes at any general meeting. It is not the AGM Information (AGM-R) itself, which would include presentations or materials shared during the meeting, nor is it an Annual Report or other financial report. Therefore, the correct classification is DVA with high confidence.
2023-06-20 English
(1) PROPOSED ADOPTION OF THE SECOND H SHARE AWARD AND TRUST SCHEME&#x3b; AND (2) PROPOSED AUTHORIZATION TO THE BOARD AND/OR THE DELEGATEE TO HANDLE MATTERS PERTAINING TO THE SECOND H SHARE AWARD
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the proposed adoption of a share award and trust scheme (the H Share Scheme) by the Board of RemeGen Co., Ltd. It details the scheme's purpose, administration, participant eligibility, and conditions for grant and vesting of awards. The document is an announcement of a proposal to be considered and approved at an Extraordinary General Meeting (EGM), and it mentions that a circular with further details and a notice of the EGM will be sent to shareholders. There is no actual financial data, financial statements, or detailed report content. The document is not a full report but an announcement related to corporate governance and shareholder meeting matters. It is not a proxy solicitation or voting results announcement but rather a regulatory announcement about a proposed share award scheme and related board authorization. Therefore, the best fitting category is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories.
2023-06-15 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.